Physician profile
Christopher R Murphy
NPI 1659787430
$6,686.82
in general payments reported to CMS, 2019-2025
38 companies · $459 in 2025
The $459 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $330 · 2020: $295 · 2021: $1,752 · 2022: $1,817 · 2023: $1,161 · 2024: $871 · 2025: $459.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,492.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,491.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Genetic Laboratories, INC. | $611.45 | 2021-2025 | Prolaris |
| Astellas Pharma US INC | $592.68 | 2020-2025 | Xtandi, Myrbetriq, Veozah |
| Coloplast Corp | $525.75 | 2021-2025 | Titan |
| Boston Scientific Corporation | $472.29 | 2019-2023 | Ams 700 Cxr Rte Kit |
| Endo Pharmaceuticals INC. | $399.49 | 2021-2023 | Edex, Aveed, Xiaflex |
| Abbvie INC. | $396.24 | 2020-2023 | |
| Janssen Biotech, INC. | $352.97 | 2020-2023 | Erleada |
| Amgen INC. | $300.64 | 2020-2023 | Xgeva, Prolia |
| Pfizer INC. | $292.50 | 2020-2025 | |
| Procept Biorobotics Corporation | $238.15 | 2024-2025 | Aquabeam System |
| Cook Medical LLC | $222.74 | 2019-2024 | Cook |
| Urogen Pharma, INC. | $207.39 | 2020-2024 | Jelmyto |
| Dendreon Pharmaceuticals LLC | $193.43 | 2022-2023 | Provenge |
| Sumitomo Pharma America, INC. | $182.17 | 2023-2025 | Gemtesa, Orgovyx |
| Allergan, INC. | $175.64 | 2020-2022 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $152.62 | 2021-2023 | |
| Tolmar, INC. | $119.81 | 2023-2025 | Jatenzo, Eligard |
| Clarus Therapeutics INC. | $119.11 | 2021 | |
| Urovant Sciences INC | $116.75 | 2021-2022 | |
| Tolmar Pharmaceuticals, INC. | $98.61 | 2021-2022 | |
| Ferring Pharmaceuticals INC. | $92.72 | 2025 | Adstiladrin |
| Blue Earth Diagnostics | $89.92 | 2021-2023 | |
| Merck Sharp & Dohme LLC | $89.07 | 2022-2025 | Keytruda, Lynparza |
| Telix Pharmaceuticals | $85.94 | 2022-2024 | Illuccix |
| Axonics, INC. | $77.61 | 2023-2024 | Axonics |
| Medtronic, INC. | $72.16 | 2021-2024 | V-Loc 180 |
| Myovant Sciences INC. | $68.68 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $60.32 | 2020-2021 | |
| Teleflex LLC | $48.45 | 2025 | Barrigel |
| Sun Pharmaceutical Industries INC. | $37.88 | 2022 | |
| Novartis Pharmaceuticals Corporation | $32.71 | 2023-2025 | |
| Verity Pharmaceuticals INC. | $29.98 | 2022 | |
| Becton, Dickinson and Company | $26.72 | 2025 | Bard Urinary Drainage Bag |
| Laborie Medical Technologies Corp. | $25.85 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
| Intuitive Surgical, INC. | $23.57 | 2022 | |
| Calyxo, INC. | $22.09 | 2025 | Cvac Aspiration System |
| 180 Medical, INC. | $18.76 | 2021 | |
| Janssen Pharmaceuticals, INC | $13.96 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Murphy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.